Equifax SEC filings document the company’s operating results, capital structure, governance, and material corporate agreements. Recent Form 8-K reports include quarterly financial-results releases and amendments to the company’s unsecured revolving credit facility involving Equifax and subsidiary borrowers.
Regulatory records also identify Equifax common stock listed on the New York Stock Exchange under EFX. Proxy materials cover annual meeting matters, board and shareholder voting topics, executive compensation, and company discussion of data, cloud technology, security, and EFX.AI within its public-company governance framework.
MCGREGOR SCOTT A reported acquisition or exercise transactions in this Form 4 filing.
Equifax director Scott A. McGregor received an equity award of 1,253 shares of common stock on May 7, 2026, recorded at $175.62 per share, as an annual director grant under the company’s long-term incentive plan. The award is structured as restricted stock units that vest 100% on May 7, 2027, meaning the shares become fully owned at that time if service conditions are met. Following this grant, McGregor directly holds 11,308 shares, which includes dividend equivalent units credited on prior restricted stock unit awards.
Equifax Inc. director Robert D. Marcus received an equity grant of 1,253 shares of common stock as a compensation award. The filing labels this as a grant or award acquisition at a reference price of $175.62 per share under the company’s long-term incentive plan.
The award consists of restricted stock units that vest 100% on May 7, 2027, and includes accrued dividend equivalent units tied to prior dividends. Following this grant, Marcus directly holds 18,349 shares of Equifax common stock.
Equifax Inc. director Barbara A. Larson received an annual equity award of 1,253 restricted stock units of common stock at a grant price of $175.62 per share. The grant was made under the company’s long-term incentive plan and is classified as an acquisition, not an open-market purchase.
The award vests 100% on May 7, 2027, aligning director compensation with longer-term performance. Following this grant, Larson directly holds 3,877 shares of Equifax common stock, which include dividend equivalent units credited on prior restricted stock unit awards.
HOUGH G. THOMAS reported acquisition or exercise transactions in this Form 4 filing.
Equifax Inc. director G. Thomas Hough received an equity award as part of his board compensation. On May 7, 2026, he was granted 1,253 shares of common stock at a grant value of $175.62 per share, described as an annual director grant under the company’s long-term incentive plan. The award consists of restricted stock units that vest 100% on May 7, 2027, and includes accrued dividend equivalent units tied to prior dividends. Following this grant, Hough directly holds 16,309 shares of Equifax common stock. This is a compensation-related award, not an open-market share purchase or sale.
Equifax director Karen L. Fichuk received an annual equity award in the form of 1,253 shares of Common Stock, recorded as a grant or award acquisition at a reference price of $175.62 per share.
The footnotes explain this is an annual director grant under the company's long-term incentive plan, structured as restricted stock units that vest 100% on 05/07/2027. Following this award, she holds 4,993 shares of Common Stock directly and 415 shares indirectly through the Karen L Fichuk Rev Trust.
Equifax director Mark L. Feidler received an equity grant valued at a set share price as part of his annual board compensation. He was awarded 1,253 shares at $175.62 per share under the company’s long-term incentive plan, structured as restricted stock units that vest 100% on May 7, 2027.
Following this grant, Feidler directly holds 25,077 shares. The position includes accrued dividend equivalent units, which reflect dividends reinvested into corresponding restricted stock units through the company’s last dividend payment date. This filing reflects a compensation-related acquisition rather than an open-market stock purchase.
Equifax executive Chad M. Borton reported selling common stock and covering taxes through share withholding. On May 7, 2026, he completed an open-market sale of 2,455 shares of Equifax common stock at $173.89 per share. On May 6, 2026, 1,934 shares were disposed of as a tax-withholding transaction at $173.20 per share, rather than an open-market sale. After these transactions, Borton directly held 29,518 shares of Equifax common stock. According to a footnote, the sales were executed under a Rule 10b5-1 trading plan adopted by the reporting person, indicating they were pre-scheduled rather than opportunistic market timing.
Equifax Inc. officer Chad M. Borton reported a proposed sale of 2,455 common shares, with an aggregate market value of $426,899.95 and an approximate sale date of May 7, 2026. The shares were acquired from the issuer through restricted stock vesting on May 6, 2026, as compensation. The notice lists November 4, 2025, as the plan adoption or instruction date if relying on Rule 10b5-1.
During the prior three months, Chad M. Borton reported selling 2,535 common shares on February 12, 2026, for gross proceeds of $485,452.50.
Equifax Inc. executive John W. Gamble Jr., EVP, CFO & COO, sold 3,500 shares of common stock in an open-market transaction. The sale occurred at a price of $176.54 per share, and he now directly holds 73,464 shares of Equifax common stock.
The transaction was carried out under a Rule 10b5-1 trading plan that he adopted on November 21, 2025, indicating the sale was pre-arranged. His holdings also include accrued dividend equivalent units tied to restricted stock units through the company’s last dividend payment date.
EQUIFAX INC (EFX) officer John W. Gamble Jr reported a proposed sale of 3,500 common shares, with an aggregate market value of $617,890 and an approximate sale date of May 1, 2026. He also sold 4,500 common shares on February 23, 2026, for gross proceeds of $880,740 during the prior three months.